Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
42.88 USD | -1.10% | -3.72% | -16.11% |
02:34pm | Bristol-Myers Squibb Says US FDA Reassigns Action Date Subcutaneous Nivolumab | MT |
01:32pm | Bristol Myers: deadline set for subcutaneous Opdivo | CF |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.11% | 87.9B | |
+38.09% | 705B | |
+32.53% | 583B | |
-3.03% | 364B | |
+20.72% | 332B | |
+5.87% | 291B | |
+16.34% | 238B | |
-3.52% | 210B | |
+10.53% | 209B | |
+9.40% | 169B |
- Stock Market
- Equities
- BMY Stock
- News Bristol-Myers Squibb Company
- Transcript : Bristol-Myers Squibb Company Presents at Leerink Partners Global Biopharma Conference 2024, Mar-13-2024 10